(11-198) Characterizing Tolerability and Outcomes of Second Line Agents Used for Pneumocystis Jirovecii Pneumonia Prophylaxis in Kidney Transplant Recipients

Wednesday, December 7, 2022

12:30 PM – 1:30 PM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Transplant/Immunology

Co-Author(s): Michael Wynd

Primary Author(s)

Syeda Rahman, PharmD
Pharmacy Resident
Hackensack University Medical Center, New Jersey